about
The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS HitsStructurally Diverse Mitochondrial Branched Chain Aminotransferase (BCATm) Leads with Varying Binding Modes Identified by Fragment ScreeningStructure-guided optimization of small molecule c-Abl activators2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesMycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jennifer A Borthwick
@ast
Jennifer A Borthwick
@en
Jennifer A Borthwick
@es
Jennifer A Borthwick
@nl
type
label
Jennifer A Borthwick
@ast
Jennifer A Borthwick
@en
Jennifer A Borthwick
@es
Jennifer A Borthwick
@nl
prefLabel
Jennifer A Borthwick
@ast
Jennifer A Borthwick
@en
Jennifer A Borthwick
@es
Jennifer A Borthwick
@nl
P106
P21
P31
P496
0000-0002-6740-4232